Skip to Content

Research & Funding

Past Other NCI & NIH InitiativesRSS

This page lists past other NCI and NIH cancer imaging initiatives, including grant mechanisms.

Requests for Application (RFA) are usually announced with special application dates; there is no possibility for applying after that date. Program Announcements (PA, PAR) may be open for a set period of time, such as 3 years or less; applications submitted in response to Program Announcements may be due on the standard dates (February 1, June1, and October 1) or may have special dates for receipt of applications. Please pay attention to these dates. Contact a CIP staff member if you have questions.

  • PAR-12-145: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)

    • Release Date: March 29, 2012
    • Application Receipt Date: Earliest submission date May 16, 2012.
    • Expiration Date: September 8, 2015
    • Contacts:

      For this FOA, please see for Scientific/Research Contacts at NCI.

    Purpose: The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).

  • DE-FOA-0000646: Integrated Nuclear Medicine Research and Training Projects of Excellence

    • Release Date: January 20, 2012
    • Application Receipt Date: Pre-Application (Required) Due Date: February 23, 2012
      Application Due Date: March 28, 2012
    • Expiration Date: March 28, 2012
    • Contacts:

      Dr. Prem Srivastava, Office of Biological and Environmental Research; Tel. 301-903-4071;

    This Funding Opportunity aims to serve three important goals:

    1. Research and development of new and highly innovative radiotracer methods and radiotracers as potential imaging agents for nuclear medicine research and application to advance the understanding of normal human physiology and gene expression, diagnosis and management of disease, in drug research and development, and in translational science;
    2. Integrated involvement of  postdoctoral fellows (Ph.D. radiochemists) and M.D., or M.D.-Ph.D fellows with specialties in Nuclear Medicine with applications to human health in developing and deploying new radiotracers for nuclear medicine imaging and potential clinical use in humans for disease-specific application;
    3. Enhancement of training opportunities to ensure the future availability of human resources for highly specialized fields of radiotracer development chemistry and clinical nuclear medicine research and allied disciplines.

    Pre-Application is Required. Pre-Application Due Date:  February 23, 2012


    • Release Date: November 12, 2010
    • Application Receipt Date: Standard dates apply
    • Expiration Date: January 8, 2014
    • Contacts:

      Jerry Li, Ph.D.; Tel. 240-276-6210; E-mail:

    • Letter of Intent Receipt Date: Not applicable

    This Funding Opportunity Announcement is aimed at satisfying one of the needs created by the parallel achievements and increased interdependence of the biological and computing sciences. This interdependence offers an unprecedented opportunity for sophisticated approaches to computer-enabled research in the biological, clinical, and behavioral sciences. The purpose of this program announcement is to assure the availability and continued usefulness of existing biomedical informatics/computational biology software. This program announcement is meant for existing software that serves a biological, clinical, or behavioral community of users. Applications under this program announcement can seek support to improve the existing software in several different ways listed below. Any of these improvements should benefit the existing user community and/or have high potential for attracting significantly more users.

    See full description in NIH Guide: PAR-11-028.